Skip to main content
Psych Congress 2023 Main banner

Full Schedule

Full Schedule

  • Thursday, September 7, 2023
  • 6:00 AM – 7:30 AM CT
    AFSP Out of the Darkness Walk
    Through our continued partnership with the American Foundation for Suicide Prevention, we are proud to announce that we will host an Out of the Darkness Community Walk at this year's Psych Congress in Nashville. Learn more, donate, and register for the walk here: www.afsp.org/psychcongress
  • 7:30 AM – 8:45 AM CT
    LAI Antipsychotic Therapy for Adults With Schizophrenia

    Innovation Theater

  • 7:30 AM – 8:45 AM CT
    Redefining the Treatment of Insomnia

    Innovation Theater

  • 9:00 AM – 10:15 AM CT
    Aging and Resilience: How to Identify and Bolster Coping Strategies in Aging Patients

    Speaker: Marc E. Agronin, MD – Miami Jewish Health

    As the global population continues to age, it is becoming increasingly important to identify effective coping strategies for older individuals. This session will explore the concept of resilience and how it relates to aging, including the potential challenges that older adults may face and the coping strategies that may be particularly helpful for this population. With a focus on the challenges faced by aging patients, we will explore how to identify and bolster coping strategies that can help patients maintain resilience in the face of those challenges.

    Click to Read More

    Geriatric Psychiatry

  • 9:00 AM – 10:15 AM CT
    Emerging Technologies and Digital Tools for the Management of ADHD

    Speaker: Greg Mattingly, MD – St.Charles Psychiatric Associates

    In this session, we will explore the latest emerging technologies and digital tools that can help manage Attention Deficit Hyperactivity Disorder (ADHD). We will discuss how these tools can improve attention, focus, and organization, and reduce symptoms of ADHD. We will also explore how digital tools such as mobile apps, wearables, and virtual reality can help individuals with ADHD manage their symptoms and improve their overall quality of life. This session is ideal for those looking to stay up-to-date on the latest advances in ADHD treatment and management.

    ADHD

    Technology

  • 9:00 AM – 10:15 AM CT
    Foundations in Psychopharmacology: Focus on Antipsychotics

    Speaker: Leslie L. Citrome, MD, MPH – Department of Psychiatry & Behavioral Sciences, New York Medical College, Valhalla, NY

    A new feature at Psych Congress in 2023, each Foundations in Psychopharmacology session will dive deep into one specific therapeutic drug class, such as antidepressants or antipsychotics. These sessions are distinct in their foundational emphasis on both long-standing medications often appropriate as first-line therapies, as well as additional first-line options and adjunctive treatments. Foundations sessions may be particularly valuable for early-career psychopharmacologists and those looking for a detailed look at the when and the why of medication selection as well as access-related challenges and considerations that may affect treatment decisions.

    Click to Read More

    Foundations

    Psychotic Disorders

    Depressive Disorders

  • 9:00 AM – 10:15 AM CT
    Integrative Treatment Approach in Reproductive Psychiatry: A Primer on Complimentary, Alternative, and non-Traditional Options

    Speaker: Anna Glezer, MD – Women's Wellness Psychiatry

    Reproductive psychiatry focuses on the management of psychiatric disorders in women during their reproductive years. The session will cover evidence-based integrative approaches to reproductive psychiatry. Participants will learn how these integrative treatments can support women's mental health during the perinatal period, and how to incorporate them into clinical practice. Overall, this session will provide valuable insights into a comprehensive approach to reproductive psychiatry that emphasizes the mind-body connection and individualized care.

    Developed in partnership with The International Society of Reproductive Psychiatry


    Click to Read More

    Women's Mental Health

  • 9:00 AM – 10:15 AM CT
    Solving Clinical Challenges: Focus on Anxiety Disorders

    Speaker: Saundra Jain, MA, PsyD, LPC – Private Practice, Austin, Texas

    Speaker: Manish K. Jha, MBBS – UT Southwestern Medical Center

    Speaker: Chelsie Monroe, APN, PMHNP-BC – Balanced Mental Wellness

    Designed to provide practical solutions to some of the most challenging patient cases, Solving Clinical Challenges sessions put our most experienced faculty on the spot to answer the question—what would you do? Exploring complex scenarios associated with real patients, our clinical panel will interact and collaborate to share insights and expertise on diagnostic challenges, psychopharmacologic and psychotherapeutic approaches, and multidisciplinary care. Practical take-aways will enable clinicians to apply advanced approaches to similarly complex patients, enhancing overall care delivery, and optimizing patient outcomes.

    Click to Read More

    Solving Clinical Challenges

    Anxiety Disorders

  • 10:30 AM – 11:45 AM CT
    A New Look at a Seasoned Solution: Improving Outcomes in Bipolar I Disorder with Long-Acting Injectable Antipsychotics

    Speaker: Christoph U. Correll, MD – (1) The Zucker Hillside Hospital; (2) Donald and Barbara Zucker School of Medicine at Hofstra/Northwell; (3) The Feinstein Institutes for Medical Research; (4) Charité - Universitätsmedizin Berlin

    Speaker: Brooke Kempf, MSN, PMHNP-BC – Hamilton Center CMHC

    Many patients with bipolar disorder struggle to adhere to prescribed treatments because of their complex daily regimens, adverse effects (AEs), and various patient-specific factors. Fortunately, several antipsychotics for BD-I have long-acting injectable (LAI) formulations, which have been shown to improve treatment adherence beyond that of standard oral formulations. Participate in this session to gain a comprehensive understanding of the safety, efficacy, and pharmacokinetics of the currently available long-acting injectable (LAI) antipsychotics for BD-I. Learn from expert faculty how to evaluate the distinctive characteristics of patients with BD-I who might benefit from LAI treatment. By integrating patient-centered care strategies, including motivational interviewing, attendees will acquire the tools to foster collaborative communication and enhance treatment acceptance among patients with BD-I.

    Click to Read More

    Master Class

  • 10:30 AM – 11:45 AM CT
    Atypical Antipsychotics for Adjunctive Treatment of MDD: Advancing the Standard of Care

    Speaker: Greg Mattingly, MD – St.Charles Psychiatric Associates

    Speaker: Leslie L. Citrome, MD, MPH – Department of Psychiatry & Behavioral Sciences, New York Medical College, Valhalla, NY

    Major depressive disorder (MDD) is plagued by inadequate treatment response and associated with significant negative quality of life (QoL) and high costs; it is estimated that less than half of patients with MDD respond to antidepressant therapy and only half of patients will ever achieve remission. This MasterClass session will explore the burden and unmet needs associated with MDD, with a special focus on patients who exhibit inadequate or partial responses to antidepressant monotherapy. In this session you will learn to identify and evaluate patient characteristics that signal a need for adjunctive treatment, enabling them to make informed decisions for tailored care. Through an in-depth exploration of the mechanisms of approved atypical antipsychotics in the context of adjunctive MDD treatment, you will gain a comprehensive understanding of how these agents impact multiple receptor systems. Furthermore, expert faculty will critically evaluate the efficacy and safety of atypical antipsychotics approved for adjunctive MDD treatment, ensuring that participants are equipped with the latest evidence-based insights.

    Click to Read More

    Master Class

  • 10:30 AM – 11:45 AM CT
    More than Skin Deep: Examining the Full Impact of Tardive Dyskinesia

    Speaker: Amber Hoberg, PMHNP-BC – Morning Star Family Medicine PLLC

    Speaker: Desiree Matthews, PMHNP-BC – Monarch, Charlotte, NC

    This MasterClass session is designed to help healthcare professionals better understand the spectrum of potential consequences beyond physical appearance for individuals with TD, including negative impacts on physical, cognitive, and psychosocial functioning. Participants will learn how to implement optimal assessment strategies for the detection and evaluation of TD and will be introduced to the VMAT-2 inhibitors approved for the condition. The session will also provide an in-depth evaluation of the practical differences between these novel treatments, equipping participants to make informed decisions about which therapy to prescribe in individual cases. By the end of the session, participants will have gained valuable knowledge and skills for providing effective care for patients with TD, improving outcomes and quality of life for this patient population.

    Click to Read More

    Master Class

  • 12:00 PM – 1:15 PM CT
    Addressing Unresolved Symptoms of Major Depressive Disorder (MDD)

    Innovation Theater

  • 12:00 PM – 1:15 PM CT
    An Established Therapy for Treatment-resistant Depression (TRD) in Adults

    Innovation Theater

  • 12:00 PM – 1:15 PM CT
    Beyond the Monoamine Hypothesis: a glutamatergic approach to treating major depressive disorder

    Innovation Theater

  • 12:00 PM – 1:15 PM CT
    Beyond Trauma: Understanding the Neurobiology and Presentation of Posttraumatic Stress Disorder.

    Innovation Theater

  • 12:00 PM – 1:15 PM CT
    The Science of TAAR1: A Potential New Target in Psychiatric Disorders

    Innovation Theater

  • 12:00 PM – 1:15 PM CT
    Understanding TD from Impact to Treatment

    Innovation Theater

  • 1:30 PM – 2:45 PM CT
    Navigating the Stimulant Crisis

    Speaker: Greg Mattingly, MD – St.Charles Psychiatric Associates

    Speaker: Julie A. Carbray, PhD, APRN – University of Illinois Chicago

    Speaker: Rakesh Jain, MD – Texas Tech - Permian Basin

    The stimulant crisis has reached a critical point, necessitating a comprehensive understanding of the challenges it presents. This session will explore the implications of recent FDA warnings in stimulant labels, strategies to manage the growing demand, and the ongoing medication shortage.

    ADHD

  • 1:30 PM – 2:45 PM CT
    State of The Science: Focus on Major Depression

    Speaker: Charles DeBattista, MD, DMH – Stanford University School of Medicine

    Depression is a complex and multifaceted mental health condition that affects millions of people around the world. In recent years, there has been an explosion of research aimed at better understanding the underlying causes of depression, as well as developing more effective treatments for the disorder. This session will provide an overview of the state of the science of depression, drawing on the latest findings and what is on the horizon.

    Click to Read More

    State of the Science

    Depressive Disorders

  • 1:30 PM – 2:45 PM CT
    Technology and Psychiatry: Updates on Artificial Intelligence and Digital Therapeutics

    Speaker: Steven R. Chan, MD, MBA – Stanford University School of Medicine, Stanford, California

    This session will explore the rapidly-evolving landscape of technology—including digital therapeutics and Artificial Intelligence—and the potential for technology to revolutionize the field of psychiatry. Through an expert-led presentation, this session will provide attendees with a comprehensive understanding of the latest technological developments and implications for the future of psychiatry.

    Technology

  • 1:30 PM – 2:45 PM CT
    Updates in Psychedelics: Where We Are Now and Where We Are Headed

    Speaker: Charles L. Raison, MD – University of Wisconsin-Madison

    Speaker: Andrew D. Penn, MS, PMHNP – University of California, San Francisco, School of Nursing

    The session will cover the most up-to-date information on the therapeutic potential of psychedelic substances and the latest findings on their effects on mental health and well-being.

    Developed in partnership with SANA

    Click to Read More

    Psychedelics

  • 1:30 PM – 2:45 PM CT
    When Does a Difference Make a Difference? How to Figure Out What's Important in Clinical Trial Results

    Speaker: Leslie L. Citrome, MD, MPH – Department of Psychiatry & Behavioral Sciences, New York Medical College, Valhalla, NY

    In this session, we will discuss the key concepts of statistical significance and clinical relevance in clinical trial results. You will gain an understanding of the difference between p-value and effect size, and how to calculate effect size. By the end of this session, you will have a clear understanding of the importance of these concepts in interpreting clinical trial results and be better equipped to differentiate between statistically significant results and those with clinical relevance. This session is essential for anyone involved in clinical research or who needs to interpret clinical trial results.

    General Psychiatry

  • 3:00 PM – 4:15 PM CT
    Managing Anxiety Disorders in 2023 and Beyond

    Speaker: Chelsie Monroe, APN, PMHNP-BC – Balanced Mental Wellness

    Speaker: Manish K. Jha, MBBS – UT Southwestern Medical Center

    The COVID-19 pandemic has caused significant disruptions in our daily lives, triggering a surge in anxiety and stress levels. This session will focus on exploring effective treatment strategies for managing anxiety, specifically for Generalized Anxiety Disorder (GAD), Obsessive Compulsive Disorder (OCD), and Agoraphobia. We will discuss the role of behavioral therapy and medication treatment in managing anxiety symptoms, including the use of virtual therapy options. Additionally, we will explore reengagement with society and practical tips for overcoming fear and anxiety in social situations.

    Anxiety Disorders

  • 3:00 PM – 4:15 PM CT
    Metabolic and Nutritional Psychiatry

    Speaker: James Greenblatt, MD – Psychiatry Redefined

    In recent years, there has been growing interest in the relationship between nutrition and mental health. This session will explore the emerging field of Nutritional and Metabolic Psychiatry and discuss the potential of leveraging diet as a key aspect of psychiatric treatment. We will review the latest research on the impact of diet on mental health and examine the mechanisms by which specific nutrients may influence brain function and behavior. We will discuss the role of insulin resistance, ketogenic diets, and micronutrient deficiencies across multiple psychiatric disorders. The practical considerations for implementing dietary and nutritional interventions in psychiatric practice will be discussed. By the end of the session, attendees will have a better understanding of the role of diet and nutritional supplementation to augment medication management.

    Integrative Care

  • 3:00 PM – 4:15 PM CT
    Optimizing Patient Outcomes Following an Initial Episode in Schizophrenia

    Speaker: Christoph U. Correll, MD – (1) The Zucker Hillside Hospital; (2) Donald and Barbara Zucker School of Medicine at Hofstra/Northwell; (3) The Feinstein Institutes for Medical Research; (4) Charité - Universitätsmedizin Berlin

    This session aims to explore the importance of early identification and intervention in the management of patients experiencing their initial schizophrenic episode. The session will cover key strategies for assessing and diagnosing early symptoms, including prodromal and attenuated psychotic symptoms. We will also discuss evidence-based interventions, including pharmacological and non-pharmacological treatments, that can improve patient outcomes and reduce the risk of relapse.

    Click to Read More

    Psychotic Disorders

  • 3:00 PM – 4:15 PM CT
    Postpartum Psychosis and Infanticide: Debunking the Myth

    Speaker: Nicole H. Cirino, MD, CST, IF, PMH-C – Baylor College of Medicine

    This session will explore the complex and often misunderstood relationship between postpartum psychosis, thoughts of harming the infant and infanticide. Although it is not uncommon for women with postpartum mood or anxiety disorders to experience thoughts of harming their infant, the overwhelming majority of women do not engage in violent behavior. This session provides an understanding of the risk factors, warning signs, and treatment options associated with infanticide. Attendees will leave this session with a greater appreciation for the complexity of diagnosing and treating women with postpartum psychosis while preserving the maternal infant bond.

    Developed in partnership with The International Society of Reproductive Psychiatry

    Click to Read More

    Women's Mental Health

    Psychotic Disorders

  • 3:00 PM – 4:15 PM CT
    The Practical Use of Ketamine
    The use of Ketamine as a potential treatment for depression and PTSD has gained significant attention in recent years. The session will provide an overview of the mechanism of action and pharmacology of Ketamine, the evidence supporting its use in these disorders, and provide practical tips for the use of Ketamine in clinical practice, including dosing, administration, monitoring, and patient selection.

    Click to Read More

    Depressive Disorders

    Trauma

  • 4:30 PM – 5:45 PM CT
    Expert Panel: Real-World Impact of Rapid-Acting Antidepressants

    Speaker: Greg Mattingly, MD – St.Charles Psychiatric Associates

    Speaker: Ahmed Baig, MD – Midwest Research Group

    Speaker: Rachel Dalthorp, MD, MHSA – LifeStance Health

    Speaker: Cheryl Meier – Midwest Research Group

    Depressive disorders are a collection of debilitating mental illnesses that affect millions of people worldwide. While traditional antidepressants can be effective, they can take weeks or even months to start working, leaving patients suffering in the meantime. Rapid-acting antidepressants are a promising new approach to treating depressive disorders that can provide relief in a matter of hours or days rather than weeks. This session will explore the latest innovations in rapid-acting antidepressant treatments, including ketamine, psilocybin, and other novel compounds. We will discuss the mechanisms of action of these drugs, their efficacy in clinical trials, and the potential risks and side effects. We will also explore the ethical implications of using these powerful drugs to treat mental illness.

    Click to Read More

    Depressive Disorders

  • 4:30 PM – 5:45 PM CT
    Integrating Shared Decision Making and Patient-Centric Interventions into Mental Health Practice

    Speaker: Rakesh Jain, MD – Texas Tech - Permian Basin

    Speaker: Maria Margaglione – Not applicable

    In today's healthcare landscape, it is essential to incorporate the patient's voice in shared decision-making, where the clinician acts as an advisor. This approach ensures that the best practices are developed by incorporating the patient's perspective. This session aims to provide clinicians with the necessary skills to incorporate patient perspectives and develop treatment plans that align with the patient's needs. We will challenge clinicians to consider how they can transform their approach to patient care and create a more patient-centered practice.

    Developed in partnership with Depression and Bipolar Support Alliance

    Click to Read More

    Patient Advocacy

    Practice Management

  • 4:30 PM – 5:45 PM CT
    Screening and Assessment for Personality Disorders

    Speaker: Mark Zimmerman, MD – Brown University

    Personality disorders are prevalent and often difficult to recognize mental health conditions, today we will be discussing screening and assessment tools. The presentation will cover various tools and techniques for screening and assessing personality disorders, including self-report measures, clinician-administered interviews, and objective measures. The importance of early detection and diagnosis of personality disorders in order to improve treatment outcomes and long-term prognosis will be highlighted.

    Click to Read More

    Personality Disorders

  • 4:30 PM – 5:45 PM CT
    When a Childhood Habit Is Something More: Exploring the Management of Pediatric Obsessive Compulsive Disorder

    Speaker: Jon E. Grant, MD – University of Chicago

    Obsessive Compulsive Disorder (OCD) is a common and disabling disorder that often manifests in childhood. It is characterized by intrusive and distressing thoughts, images, or impulses (obsessions) that are accompanied by repetitive behaviors or mental acts (compulsions) aimed at reducing the anxiety caused by the obsessions. The management of OCD in children can be challenging, and early diagnosis and treatment are critical for preventing long-term disability.

    Click to Read More

    Child and Adolescent Psychiatry

    Obsessive-Compulsive Disorders

  • 6:00 PM – 7:45 PM CT
    Exhibit Hall
  • 6:30 PM – 7:30 PM CT
    Becoming a Women's Mental Health Practitioner in 2023